Pyxis Oncology, Inc.
SEC CIK 1782223 · PYXS · last insider filing 2026-03-25
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Flavin John L | Director | filed 2021 - 2026 |
| Lewis-Hall Freda C | Director | filed 2021 - 2026 |
| Metzger Michael A | Director | filed 2024 - 2026 |
| Dupont Jakob | Director | filed 2023 - 2026 |
| Humphrey Rachel | Director | filed 2022 - 2026 |
| Cline Darren S | Director | filed 2021 - 2026 |
| Palani Santhosh | Director | filed 2024 - 2026 |
| Civik Thomas | Director · Interim CEO | filed 2021 - 2026 |
| Sullivan Lara | Director · President and CEO | filed 2021 - 2025 |
| Chin Mark | Director | filed 2021 - 2022 |
| Chen Bihua | Director | filed 2021 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Wadhane Jitendra | SVP, Chief Accounting Officer | filed 2022 - 2026 |
| Yanchik Connealy Pamela | Chief Financial Officer | filed 2021 - 2025 |
| Kobayashi Ken | Chief Medical Officer | filed 2023 - 2023 |
| Feingold Jay | Chief Medical Officer | filed 2021 - 2023 |
| Shah Ritu | Chief Operating Officer | filed 2021 - 2021 |
| Herbst Ronald | Chief Scientific Officer | filed 2021 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.